ArticleNPJ breast cancer2023

TRIM21 mediates the synergistic effect of Olaparib and Sorafenib by degrading BRCA1 through ubiquitination in TNBC.

Ning Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.